References
- Norris J S, Gorski J, Kohler P O. Androgen receptors in a Syrian hamster ductus deferens tumor cell line. NATURE 1974; 248: 422–424
- Norris J S, Garmer D J, Brown F, Popovich K, Cornet L E. Characteristics of an adenylate cyclase coupled β2-adrenergic receptor in a smooth muscle tumor cell line. J RECEPTOR RES 1983; 3: 623–645
- Cornett L E, Ball D W, Norris J S. α1-adrenergic receptors of a smooth muscle cell line: guanine nucleotides do not regulate agonist affinities. J RECEPTOR RES 1982; 2: 601–615
- Cornett L E, Norris J S. Characterization of the α1-adrenergic subtype in a smooth muscle cell line. J BIOL CHEM 1982; 257: 694–697
- Lacovic Z, Relja M. Evidence for a widely distributed peripheral dopaminergic system. FEDERATION PROC 1983; 42: 3000–3004
- Relja M, Lackovic Z, Neff M H. Evidence for the presence of dopaminergic receptors in vas deferens. LIFE SCIENCES 1982; 31: 2571–2575
- Seeman P. Brain dopamine receptors. PHARMACOL REV 1981; 32: 229–313
- List S J, Seeman P. Resolution of dopamine and serotonin receptor components of (3H) spiperone binding to rat brain regions. PROC NATL ACAD SCI 1981; 78: 2620–2624
- Bradford M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. ANAL BIOCHEM 1973; 72: 248–254
- Munson P J, Rodbard D. LIGAND: A versatile computerized approach for characterization of ligand-binding systems. ANAL BIOCHEM 1980; 107: 220–239
- Delean A, Munson P J, Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay and physiological dose-response curves. AM J PHYSIOL 1978; 235: E97–E102
- Cheng Y, Prusoff W H. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (IC50) of an enzymatic reaction. BIOCHEM PHARMACOL 1973; 22: 2099–2108
- Leysen J E, Gommeren W, Laduron P M. Spiperone: a ligand of choice for neuroleptic receptors. BIOCHEMICAL PHARMACOL 1978; 27: 307–316
- Laudron P M. Criteria for receptor sites in binding studies. BIOCHEM PHARMACOL 1984; 33: 833–839
- Peroutka S J, U'Prichard D C, Greenberg D A, Snyder S H. Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brain. NEUROPHARMACOL 1977; 16: 540–556
- Leysen J E, Awouters F, Kennis L, Laudron P M, Vandenberk J, Janssen P AJ. Receptor binding profile of R 41468, a novel antagonist at 5-HT2 receptors. LIFE SCIENCES 1981; 28: 1015–1022
- Andorn A C, Maquire M E. (3H) Spiroperidol binding in rat striatum: Two high-affinity sites of differing selectivities. J NEUROCHEM 1980; 35: 1105–1113
- Morgan D G, Marcusson J G, Finch C E. Contamination of serotonin-2 binding sites by an alpha-1 adrenergic component in assays with (3H) spiperone. LIFE SCIENCES 1984; 34: 2507–2514
- Hamblin M W, Leff S E, Creese I. Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes. BIOCHEM PHARMACOL 1984; 33: 877–887
- Withy R M, Mayer R J, Strange P G. Use of (3H) spiperone for labelling dopaminergic and serotonergic receptors in bovine caudate nucleus. J NEUROCHEM 1981; 37: 1144–1154
- Greenberg D A, Snyder S H. Pharmacological properties of (3H) dihydroergokryptine binding sites associated with alpha-noradrenergic receptors in rat brain membranes. MOL PHARMACOL 1978; 14: 38–49